Compare with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES FRESENIUS KABI ONCO. ALKEM LABORATORIES/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 22.2 22.1 100.4% View Chart
P/BV x 5.4 3.1 172.2% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 ALKEM LABORATORIES   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
FRESENIUS KABI ONCO.
Mar-13
ALKEM LABORATORIES/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs2,720176 1,545.5%   
Low Rs1,66079 2,115.1%   
Sales per share (Unadj.) Rs697.937.7 1,851.8%  
Earnings per share (Unadj.) Rs96.15.1 1,887.2%  
Cash flow per share (Unadj.) Rs117.36.7 1,744.1%  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs515.242.5 1,211.1%  
Shares outstanding (eoy) m119.57158.23 75.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.13.4 92.9%   
Avg P/E ratio x22.825.0 91.2%  
P/CF ratio (eoy) x18.718.9 98.7%  
Price / Book Value ratio x4.33.0 142.1%  
Dividend payout %26.00-   
Avg Mkt Cap Rs m261,87920,135 1,300.6%   
No. of employees `00014.31.2 1,244.0%   
Total wages/salary Rs m15,055703 2,140.9%   
Avg. sales/employee Rs Th5,822.65,176.2 112.5%   
Avg. wages/employee Rs Th1,050.5610.4 172.1%   
Avg. net profit/employee Rs Th802.0699.6 114.6%   
INCOME DATA
Net Sales Rs m83,4445,963 1,399.4%  
Other income Rs m1,04218 5,790.0%   
Total revenues Rs m84,4865,981 1,412.6%   
Gross profit Rs m14,7341,430 1,030.3%  
Depreciation Rs m2,528258 980.1%   
Interest Rs m651-26 -2,502.3%   
Profit before tax Rs m12,5981,216 1,035.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m1,105342 322.9%   
Profit after tax Rs m11,493806 1,426.1%  
Gross profit margin %17.724.0 73.6%  
Effective tax rate %8.828.1 31.2%   
Net profit margin %13.813.5 101.9%  
BALANCE SHEET DATA
Current assets Rs m54,9605,102 1,077.3%   
Current liabilities Rs m32,4332,385 1,359.7%   
Net working cap to sales %27.045.6 59.3%  
Current ratio x1.72.1 79.2%  
Inventory Days Days80150 53.0%  
Debtors Days Days72113 63.7%  
Net fixed assets Rs m32,7105,148 635.4%   
Share capital Rs m239158 151.1%   
"Free" reserves Rs m61,3686,556 936.1%   
Net worth Rs m61,6076,732 915.2%   
Long term debt Rs m1,592952 167.2%   
Total assets Rs m99,43310,388 957.2%  
Interest coverage x20.4-45.8 -44.5%   
Debt to equity ratio x00.1 18.3%  
Sales to assets ratio x0.80.6 146.2%   
Return on assets %12.27.5 162.7%  
Return on equity %18.712.0 155.8%  
Return on capital %21.014.6 143.6%  
Exports to sales %19.174.5 25.6%   
Imports to sales %3.024.8 12.0%   
Exports (fob) Rs m15,9174,441 358.4%   
Imports (cif) Rs m2,4831,477 168.1%   
Fx inflow Rs m16,0615,298 303.2%   
Fx outflow Rs m2,4831,772 140.1%   
Net fx Rs m13,5783,525 385.2%   
CASH FLOW
From Operations Rs m5,8511,274 459.2%  
From Investments Rs m-7,414-1,204 615.6%  
From Financial Activity Rs m792-196 -403.6%  
Net Cashflow Rs m-731-126 578.9%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 33.1 0.3 11,033.3%  
FIIs % 0.0 9.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 9.1 -  
Shareholders   68,381 42,599 160.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   NEULAND LABS  DR. REDDYS LAB  GSK PHARMA  ALEMBIC  PROCTER & GAMBLE HEALTH  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 200 Points Higher; Dow Futures Up by 165 Points(12:30 pm)

Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 299 points, up 0.6% at 50,739 levels.

Related Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

Charge Your Portfolio with this Smallcap Proxy Play on India's EV Revolution(Profit Hunter)

Mar 5, 2021

This could be the biggest wealth creator of the decade.

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Mar 9, 2021 03:36 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - IPCA LABS COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS